Search Results
Oct 21, 2025, 08:23 ET Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers
Preclinical Summary (2025): Potent gene-level target suppression: HT-KIT achieved >80% reduction of KIT mRNA/protein across in-vitro systems and in vivo models of systemic mastocytosis
More news about: Hoth Therapeutics, Inc.
Oct 21, 2025, 08:05 ET Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
functional activity. Notably, no participant developed anti-drug antibodies (ADA) across ~1,000 blood samples. ADA is a common challenge observed in other gene-based delivery platforms, such as adeno-associated virus (AAV) mediated antibody expression. Additionally, the DMAbs were well tolerated, with the most
More news about: INOVIO Pharmaceuticals, Inc.
Oct 21, 2025, 08:03 ET What Will Define the Future of Pharma? Five Trends on Solvias' Radar Ahead of CPHI Frankfurt 2025
expert teams combine deep scientific insight with regulatory expertise across small molecules, biologics, and advanced modalities including cell and gene therapies. We deliver end-to-end analytical solutions spanning raw material testing, method development and validation, through to drug product release
More news about: Solvias
Oct 21, 2025, 08:00 ET Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics
About Gene Tools LLC Since 1997, Gene Tools has specialized in designing and manufacturing customizable PMOs for research use. As the first company to commercially offer PMOs to researchers, we remain passionately committed to evolving research needs. Gene Tools offers
More news about: Ajinomoto Bio-Pharma Services
Oct 21, 2025, 08:00 ET Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics
About Gene Tools LLC Since 1997, Gene Tools has specialized in designing and manufacturing customizable PMOs for research use. As the first company to commercially offer PMOs to researchers, we remain passionately committed to evolving research needs. Gene Tools offers
More news about: Ajinomoto Bio-Pharma Services
Oct 21, 2025, 08:00 ET Virtuosi® 2.0 - Unleashed
Learning Content IACET-accredited modules spanning the most critical topics such as Aseptic Processing, Cell & Gene Therapies, and Microbiology — integrated with the most advanced regulatory frameworks to ensure global GMP compliance readiness. Content tailored to
More news about: Quality Executive Partners, Inc.
Oct 21, 2025, 08:00 ET Virtuosi® 2.0 - Unleashed
Learning Content IACET-accredited modules spanning the most critical topics such as Aseptic Processing, Cell & Gene Therapies, and Microbiology — integrated with the most advanced regulatory frameworks to ensure global GMP compliance readiness. Content tailored to
More news about: Quality Executive Partners, Inc.
Oct 21, 2025, 03:30 ET Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™
" Astraveus' closed, automated, and truly end-to-end approach to cell therapy manufacturing has the potential to transform the autologous cell and gene therapy landscape. I am deeply passionate about helping to expand access to these transformative medicines for patients in need."
More news about: Astraveus
Oct 20, 2025, 14:30 ET Breakthrough Discovery Identifies the Cause of Bipolar Disorder
New book by William J. Walsh, Ph.D., reveals how ion channel gene weaknesses and DNA damage drive the mania–depression cycle. NAPERVILLE, Ill., Oct. 20, 2025
More news about: Walsh Research Institute
Oct 20, 2025, 11:00 ET Resistance to Epilepsy Treatments May Wane Over Time
Therapeutics, Receptor Holdings, RiverVest, Sage Therapeutics, SK Life Science, Stoke Therapeutics, Supernus Pharmaceuticals, Takeda Pharmaceuticals, Taysha Gene Therapies, Third Rock Ventures, UCB, uniQure, Ventus Therapeutics, Vida Ventures, and Xenon Pharmaceuticals. French has received additional research
More news about: NYU Grossman School of Medicine and NYU Langone Health
Oct 20, 2025, 09:37 ET Orsini Launches Integrated Specialty Pharmacy and 3PL Solution at Columbus, Ohio Facility
strengthens Orsini's infrastructure with comprehensive specialty pharmacy redundancy, co-located 3PL capabilities, and advanced ultra-cold storage to support gene and cell therapy programs. By combining specialty pharmacy and 3PL services under one roof, Orsini delivers an integrated model designed specifically
More news about: Orsini
Oct 20, 2025, 08:05 ET Student Transportation of America Recognizes Six Terminals with Regional Safety Challenge Awards
community-wide commitment, from students staying aware at the curb to motorists sharing the road responsibly, to the highly trained drivers behind the wheel," Gene Kowalczewski, CEO of Student Transportation of America. "National School Bus Safety Week is the perfect time to celebrate those collective efforts,
More news about: Student Transportation of America
Oct 20, 2025, 07:43 ET Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London
2nd panel: Gene Therapy and mRNA Therapeutics Explore how gene and mRNA therapies are translating promise into practice, tackling challenges in delivery, durability,
More news about: GenScript Biotech Corporation
Oct 20, 2025, 01:56 ET Chengdu CATANIA's Tower 2 Debuts Globally: A 222-Meter-High Sky Residence Redefining Global Luxury Living.
its international standing. This recognition stems from its core advantages—an unrivaled location, top-tier amenities, and a deeply integrated art gene. These qualities have cemented its status not only as a world-class luxury residence but as a Chengdu landmark on the global luxury residence stage.
More news about: CNS
Oct 18, 2025, 13:38 ET HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
David KORNBERG Prof. Kornberg, a Nobel laureate in Chemistry, is renowned for his groundbreaking work on gene transcription. Prof. Kornberg followed in his father's footsteps to make significant contributions to molecular biology. His discovery of the nucleosome
More news about: The Hong Kong University of Science and Technology
Oct 18, 2025, 13:27 ET HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
David KORNBERG Prof. Kornberg, a Nobel laureate in Chemistry, is renowned for his groundbreaking work on gene transcription. Prof. Kornberg followed in his father's footsteps to make significant contributions to molecular biology. His discovery of the nucleosome
More news about: The Hong Kong University of Science and Technology
Oct 17, 2025, 15:36 ET At 2025 STAT Summit, Guests including Joe Kennedy III, AMA President, Former NIH Leaders, Explore CRISPR, Pharma, Public Health, and More
Leaders debate CRISPR, pharma, public health, policy & more. Kyle, Nicole, and KJ Muldoon, a family on the receiving end of a gene-editing milestone. In a scientific first, CRISPR was used to correct a misspelling in KJ's genes when he was just 6 months old — a breakthrough that
More news about: STAT
Oct 17, 2025, 13:03 ET North Carolina Community College System Launches Presidential Search Backed by Statewide Council of Business and Government Leaders
Dr. Amanda Lee, President, NC Association of Community College Presidents Gene Rees, Chairman, Board, NC Association of Community College Trustees Chris Chung, CEO, Economic Development Partnership of
More news about: North Carolina Community College System
Oct 17, 2025, 10:31 ET Gene Siskel Film Center of the School of the Art Institute of Chicago Announces Full Program for the 31st Annual Black Harvest Film Festival
Note: Showtimes and guest appearances are subject to change. About the Gene Siskel Film CenterFor more than 50 years, the Gene Siskel Film Center has welcomed cinephiles and curious newcomers alike to experience a curated collection of the world's
More news about: School of the Art Institute of Chicago
Oct 17, 2025, 10:00 ET Boehringer's HERNEXEOS® demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
advanced cancer (solid tumors with changes in the HER2 (ERRB2) gene) for whom previous treatment was not successful. The second part is open to people with advanced NSCLC with a specific mutation in the HER2 (ERBB2) gene. Beamion LUNG-2 (NCT06151574) is a Phase III, open label, randomized,
More news about: Boehringer Ingelheim
Oct 17, 2025, 07:00 ET CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Headquartered in Bridgewater,
More news about: Insmed Incorporated
Oct 17, 2025, 04:38 ET Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM Intelligence
45.1% market share, translating to approximately US $988 million in global revenue. This segment includes exon-skipping RNA therapeutics and gene replacement therapies that directly target the underlying genetic defect. Steroidal and NSAID therapies-once
More news about: DataM Intelligence 4 Market Research LLP
Oct 16, 2025, 22:06 ET Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
SMN1 , which is associated with spinal muscular atrophy but is difficult to detect based on the highly homologous SMN2 gene; NCF1 , which is associated with an inherited
More news about: Illumina
Oct 16, 2025, 14:40 ET DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects
noted Houda Hachad, PharmD and Vice President of Clinical Operations at Aranscia. The DPYD gene produces dihydropyrimidine dehydrogenase (DPD), an enzyme responsible for metabolizing these medications. DPYD gene variants may cause DPD deficiencies, leading to dangerously high or toxic accumulations of
More news about: Aranscia
Oct 16, 2025, 14:30 ET Nabsys Presents Novel Disease Insights and Advantages in Structural Variant Detection using OhmX™ Platform at American Society of Human Genetics (ASHG) 2025 Annual Meeting
100 individuals from the Maryland Genetics of Interstitial Cystitis Study (MaGIC) Cohort (N=348 total). Data was further analyzed using gene-based collapsing, gene set, exome-wide association study (ExWAS), trio and diagnostic approaches and compared to 11,981 controls.
More news about: Nabsys